Factors associated with adherence to phosphodiesterase type 5 inhibitors for the treatment of pulmonary arterial hypertension.

Journal of medical economics

Volumn 16, Issue 2, 2013, Pages 298-306

  Waxman, Aaron ^a   Chen, Shih Yin ^b   Boulanger, Luke ^b   Watson, Jay A ^b   Golden, Gil ^b  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

PHOSPHODIESTERASE V INHIBITOR;

ADOLESCENT; ADULT; AGED; ARTICLE; CONFIDENCE INTERVAL; FEMALE; HUMAN; INSURANCE; MALE; MEDICATION COMPLIANCE; MIDDLE AGED; PHARMACY; PULMONARY HYPERTENSION; RISK; STATISTICAL MODEL; STATISTICS;

ADOLESCENT; ADULT; AGED; COMMUNITY PHARMACY SERVICES; CONFIDENCE INTERVALS; FEMALE; HUMANS; HYPERTENSION, PULMONARY; INSURANCE CLAIM REVIEW; LOGISTIC MODELS; MALE; MEDICATION ADHERENCE; MIDDLE AGED; ODDS RATIO; PHOSPHODIESTERASE 5 INHIBITORS; YOUNG ADULT;

EID: 84879021106     PISSN: None     EISSN: 1941837X     Source Type: None    
DOI: 10.3111/13696998.2012.756399     Document Type: Article

References (0)